C-N1UJIntervene Immune
thymus regeneration, immune monitoring, epigenetic clocks
repairingbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-N1UJ
C-N1UJC-N1UJthymus regeneration, immune monitoring, epigenetic clocks
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Intervene Immune thymus regeneration, immune monitoring, epigenetic clocks
Intervene Immune presents itself as a company translating aging biology into treatments that rejuvenate the immune system and enhance human longevity. Its site centers on the TRIIM and TRIIM-X studies, which it says demonstrated thymus regeneration and epigenetic age reversal in humans. The company also offers or plans immune monitoring services and lists a clinical development pipeline spanning somatropin, GH biobetters, immune tolerance biologics, and small-molecule target discovery.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Intervene Immune — Far from goals · Lower middle. Derived deterministically from 3 extracted project(s). Most-advanced status: exploratory. Band: far. Modifiers: +5 depth (3 programs at exploratory).…
Source: Deterministic